Merck KGaA (ETR: MRK)
Germany
· Delayed Price · Currency is EUR
150.60
+2.10 (1.41%)
Jan 30, 2025, 12:09 PM CET
Merck KGaA Revenue
Merck KGaA had revenue of 5.27B EUR in the quarter ending September 30, 2024, with 1.80% growth. This brings the company's revenue in the last twelve months to 20.96B, down -2.17% year-over-year. In the year 2023, Merck KGaA had annual revenue of 20.99B, down -5.57%.
Revenue (ttm)
20.96B
Revenue Growth
-2.17%
P/S Ratio
3.08
Revenue / Employee
336.73K
Employees
62,908
Market Cap
64.56B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 20.99B | -1.24B | -5.57% |
Dec 31, 2022 | 22.23B | 2.55B | 12.93% |
Dec 31, 2021 | 19.69B | 2.15B | 12.28% |
Dec 31, 2020 | 17.53B | 1.38B | 8.56% |
Dec 31, 2019 | 16.15B | 1.32B | 8.87% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 22.36B |
Bayer Aktiengesellschaft | 46.74B |
Fresenius SE & Co. KGaA | 22.81B |
Sartorius Aktiengesellschaft | 3.32B |
Fresenius Medical Care AG | 19.24B |
Carl Zeiss Meditec AG | 2.07B |
Fielmann Group AG | 2.16B |
SCHOTT Pharma AG & Co. KGaA | 957.09M |
Merck KGaA News
- 7 days ago - Merck KGaA says high asset prices call for prudent M&A approach - Reuters
- 7 days ago - MilliporeSigma Partners with Opentrons Labworks, Inc., Supporting Lab of the Future - Financial Post
- 8 days ago - Merck KGaA, Darmstadt, Germany Announces Launch of Caregiver Leave Benefit, Strengthening Inclusive Family-Friendly Offerings - Financial Post
- 8 days ago - EU ship can be 'turned around,' Merck KGaA CEO says - CNBC
- 22 days ago - Mirror Biologics Enters Clinical Collaboration with Merck KGaA, Darmstadt, Germany in Metastatic Colorectal Cancer - GlobeNewsWire
- 24 days ago - MilliporeSigma Acquires HUB Organoids Holding B.V., Expands Next-Gen Biology Portfolio - Financial Post
- 6 weeks ago - MilliporeSigma to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio - Financial Post
- 2 months ago - Merck KGaA (MKGAF) Q3 2024 Earnings Call Transcript - Seeking Alpha